CIPNX
Price
$18.84
Change
+$0.11 (+0.59%)
Updated
Jul 31 closing price
Net Assets
752.92M
VEXRX
Price
$122.04
Change
-$0.34 (-0.28%)
Updated
Jul 31 closing price
Net Assets
23.31B
Interact to see
Advertisement

CIPNX vs VEXRX

CIPNX vs VEXRX Comparison Chart in %
View a ticker or compare two or three
VS
CIPNX vs. VEXRX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIPNX is a Buy and VEXRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 23.3B vs. CIPNX (753M). VEXRX pays higher dividends than CIPNX: VEXRX (0.49) vs CIPNX (0.00). CIPNX was incepted earlier than VEXRX: CIPNX (10 years) vs VEXRX (25 years). CIPNX (0.99) is less costly to investors than VEXRX (0.28). CIPNX (51.00) and VEXRX (51.00) have comparable annual turnover. VEXRX has a lower initial minimum investment than CIPNX: VEXRX (50000) vs CIPNX (1000000). VEXRX annual gain was more profitable for investors over the last year : 14.58 vs. CIPNX (-14.79). VEXRX return over 5 years is better than : -10.11 vs. CIPNX (-26.06).
CIPNXVEXRXCIPNX / VEXRX
Total Expense Ratio0.990.28354%
Annual Report Gross Expense Ratio0.990.28354%
Fund Existence10 years25 years-
Gain YTD7.65714.38753%
Front LoadN/AN/A-
Min. Initial Investment1000000500002,000%
Min. Initial Investment IRAN/AN/A-
Net Assets753M23.3B3%
Annual Yield % from dividends0.000.49-
Returns for 1 year-14.7914.58-101%
Returns for 3 years-15.9322.28-71%
Returns for 5 years-26.06-10.11258%
Returns for 10 yearsN/A54.76-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AFVLX26.450.06
+0.23%
Applied Finance Select Investor
THPGX135.090.02
+0.01%
Thompson LargeCap
RAPAX12.30-0.06
-0.49%
Cohen & Steers Real Assets A
GCISX20.13-0.12
-0.59%
Goldman Sachs Intl Eq Insghts S
NUGAX36.69-0.29
-0.78%
Nuveen Global Dividend Growth A